Related Experiment Videos
Aspirin "allergy" and resistance
Journal of the American College of Cardiology
|August 18, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Thalassemia in Bangladesh: progress, challenges, and a strategic blueprint for prevention.
Orphanet journal of rare diseases·2025
Evaluating the therapeutic potential of tofacitinib in Sjögren's disease: a comprehensive clinical and immunological assessment.
Rheumatology (Oxford, England)·2025
Metformin-induced activation of Ca<sup>2+</sup> signaling prevents immune infiltration/pathology in Sjogren's syndrome-prone mouse models.
Journal of translational autoimmunity·2023
Marginal Zone B (MZB) Cells: Comparison of the Initial Identification of Immune Activity Leading to Dacryoadenitis and Sialadenitis in Experimental Sjögren's Syndrome.
International journal of molecular sciences·2023
Aspirin Withdrawal in Patients With Coronary Artery Disease.
Journal of the American College of Cardiology·2026
The Role of Coronary Artery Calcium in Statin Eligibility Based on the American Heart Association's PREVENT Calculator: Insights From MESA.
Journal of the American College of Cardiology·2026
Myocardial Scar Assessment Using Artificial Intelligence-Powered Contrast-Free MRI: A Prospective Multicenter Study of Virtual Native Enhancement.
Journal of the American College of Cardiology·2026
Long-Term Exposure to PM<sub>2.5</sub> Constituents and Coronary Heart Disease Risk in China.
Journal of the American College of Cardiology·2026
Cardiovascular Health Change Patterns After Multifaceted Antihypertensive Intervention and Cardiovascular Outcomes: A Post Hoc Analysis of CRHCP Trial.
Journal of the American College of Cardiology·2026
Natural History of Asymptomatic Phenotypically Mild HCM: Insights From the SHaRe Registry.
Journal of the American College of Cardiology·2026
Upadacitinib for refractory generalized lichen sclerosus: a case report and brief literature review.
Frontiers in immunology·2026
Case Report: A case report of bullous pemphigoid triggered by sintilimab (PD-1 inhibitor).
Frontiers in immunology·2026